Taming Amphotericin B

Bioconjugate Chemistry

Volumn 26, Issue 10, 2015, Pages 2021-2024

  Janout, Vaclav ^a   Schell, Wiley A ^b   Thévenin, Damien ^a   Yu, Yuming ^a   Perfect, John R ^b   Regen, Steven L ^a  

^a LEHIGH UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID MOLECULES; AMPHOTERICIN B; ANTIFUNGAL ACTIVITIES; CELLULARS; CHOLIC ACIDS; CYTOTOXCITY; HEMOLYTIC ACTIVITY; POWER; SHARP CONTRAST; SPERMIDINE;

AMPHOTERICIN B; ANTIFUNGAL AGENT; CHOLIC ACID; HEMOLYTIC AGENT; SPERMIDINE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CELL KILLING; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; FUNGAL CELL; IN VITRO STUDY; LIPID MEMBRANE; MEMBRANE DAMAGE; NONHUMAN; T LYMPHOCYTE; ANIMAL; CHEMISTRY; DRUG EFFECTS; ERYTHROCYTE; HEK293 CELL LINE; HUMAN; PRECLINICAL STUDY; PROCEDURES; STRUCTURE ACTIVITY RELATION;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; CHOLIC ACID; DRUG EVALUATION, PRECLINICAL; ERYTHROCYTES; HEK293 CELLS; HEMOLYTIC AGENTS; HUMANS; SPERMIDINE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84945395724     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.5b00463     Document Type: Article

References (28)

1. Falci, D. R., da Rosa, F. B., and Pasqualotto, A. C. (2015) Comparison of nephrotoxicity associated to different lipid formulations of amphotericin b: a real-life study Mycoses 58, 104-112 10.1111/myc.12283
2. Kaminski, D. M. (2014) Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments Eur. Biophys. J. 43, 453-467 10.1007/s00249-014-0983-8
3. Tevyashova, A. S., Olsufyeva, E. N., Solovieva, S. E., Printsevskaya, S. S., Reznikova, M. I., Trenin, A. S., Galatenko, O. A., Treshalin, I. D., Pereverzeva, E. R., and Mirchink, E. P. et al. 2013, Structure-antifungal activity relationships of polyene antibiotics of the amphotericin b group Antimicrob. Agents Chemother. 57, 3815-3822 10.1128/AAC.00270-13
4. Wilcox, B. C., Endo, M. M., Uno, B. E., and Burke, M. D. (2013) C2′-OH of amphotericin b plays an important role in binding the primary sterol of human cells but not yeast cells J. Am. Chem. Soc. 135, 8488-8491 10.1021/ja403255s
5. Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., and White, T. C. (2012) Hidden killers: human fungal infections Sci. Transl. Med. 4, 1-9 10.1126/scitranslmed.3004404
6. Palacios, D. S., Dailey, I., Siebert, D. M., Wilcock, B. C., and Burke, M. D. (2011) Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities Proc. Natl. Acad. Sci. U. S. A. 108, 6733-6738 10.1073/pnas.1015023108
7. Volmer, A. A., Szpilman, A. M., and Carreira, E. M. (2010) Synthesis and biological evaluation of amphotericin B derivatives Nat. Prod. Rep. 27, 1329-1349 10.1039/b820743g
8. Neumann, A., Baginski, M., and Czub, J. (2010) How do sterols determine the antifungal activity of amphotericin B? Free energy of binding between the drug and its membrane targets J. Am. Chem. Soc. 132, 18266-18272 10.1021/ja1074344
9. Sedlak, M. (2009) Amphotericin B: from derivatives to covalent targeted conjugates Mini-Rev. Med. Chem. 9, 1306-1316 10.2174/138955709789878178
10. Monk, B. C. and Goffeau, A. (2008) Outwitting multidrug resistance to antifungals Science 321, 367-369 10.1126/science.1159746
11. Bolard, J. (1986) How do polyene macrolide antibiotics affect the cellular membrane properties? Biochim. Biophys. Acta, Rev. Biomembr. 864, 257-304 10.1016/0304-4157(86)90002-X
12. Davis, S. A., Vincent, B. M., Endo, M. M., Whitesell, L., Marchillo, K., Andes, D. R., Lindquist, S., and Burke, M. D. (2015) Nontoxic antimicrobials that evade drug resistance Nat. Chem. Biol. 11, 481-487 10.1038/nchembio.1821
13. Gray, K. C., Palacios, D. S., Dailey, I., Endo, M. M., Uno, B. E., Wilcock, B. C., and Burke, M. D. (2012) Amphotericin primarily kills yeast by simply binding ergosterol Proc. Natl. Acad. Sci. U. S. A. 109, 2234-2239 10.1073/pnas.1117280109
14. Anderson, T. M., Clay, M. C., Cioffi, A. G., Diaz, K. A., Hisao, G. S., Tuttle, M. D., Nieuwkoop, A. J., Comellas, G., Maryum, N., and Wang, S. et al. 2014, Amphotericin forms an extramembranous and fungicidal sterol sponge Nat. Chem. Biol. 10, 400-406 10.1038/nchembio.1496
15. Legrand, P., Romero, E. A., Cohen, B. E., and Bolard, J. (1992) Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes Antimicrob. Agents Chemother. 36, 2518-2522 10.1128/AAC.36.11.2518
16. Yamashita, K., Janout, V., Bernard, E. M., Armstrong, D., and Regen, S. L. (1995) Micelle/monomer control over the membrane-disrupting properties of an amphiphilic antibiotic J. Am. Chem. Soc. 117, 6249-6253 10.1021/ja00128a011
17. Liu, Y. and Regen, S. L. (1993) Control over vesicle rupture and leakage by membrane packing and by the aggregation state of an attacking surfactant J. Am. Chem. Soc. 115, 708-713 10.1021/ja00055a047
18. Juliano, R. L., Grant, C. W., Barber, K. R., and Kalp, M. A. (1987) Mechanism of the selective toxicity of amphotericin B incorporated into liposomes Mol. Pharmacol. 31, 1-11
19. Kondo, M., Mehiri, M., and Regen, S. L. (2008) Viewing membrane-bound molecular umbrellas by parallax analyses J. Am. Chem. Soc. 130, 13771-13777 10.1021/ja804929m
20. Stadler, E., Dedek, P., Yamashita, K., and Regen, S. L. (1994) Amphotericin B mimics: a sterol-based ionophore J. Am. Chem. Soc. 116, 6677-6682 10.1021/ja00094a024
21. Janout, V. and Regen, S. L. (2009) Bioconjugate-based molecular umbrellas Bioconjugate Chem. 20, 183-192 10.1021/bc800296g
22. Arranz-Gibert, P., Guixer, B., Malakoutikhah, M., Muttenthaler, M., Guzman, F., Teixido, M., and Giralt, E. (2015) Lipid bilayer crossing-the gate symmetry. Water-soluble phenylproline-based blood-brain barrier shuttles J. Am. Chem. Soc. 137, 7357-7364 10.1021/jacs.5b02050
23. Shao, K., Huang, R., Li, J., Han, L., Ye, L., Lou, J., and Jiang, C. (2010) Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B deliery targeted to the brain J. Controlled Release 147, 118-126 10.1016/j.jconrel.2010.06.018
24. Pyrgos, V., Mickiene, D., Sein, T., Cotton, M., Fransesconi, A., Mizrahi, I., Donoghue, M., Bundrant, N., Kim, S. Y., and Hardwick, M. et al. 2010, Effects of immunomodulatory and organism-associated molecules on the permeability of an in vitro blood-brain barrier model to amphotericin B and fluconazole Antimicrob. Agents Chemother. 54, 1305-1310 10.1128/AAC.01263-09
25. Gaspar, D., Velga, A. S., and Castanho, M. H. (2013) From antimicrobial to anticancer peptides. A review Front. Microbiol. 4, 1-16 10.3389/fmicb.2013.00294
26. Jennings, M. C., Minbiole, K. P. C., and Wuest, W. M. (2015) Quaternary ammonium compounds: an antimicrobial mainstay and platform for innovation to address bacterial resistance ACS Infect. Dis. 1, 288-303 10.1021/acsinfecdis.5b00047
27. Joondan, N., Caumul, P., Akerman, M., and Jhaumeer-Laullo, S. (2015) Synthesis, micellization and interaction of novel quaternary ammonium compounds derived from L-phenylalanine with 1,2-dipalmitoyl-sn-glycero-3-phosphocholine as model membrane in relation to their antibacterial activity, and their selectivity over human red blood cells Bioorg. Chem. 58, 117-129 10.1016/j.bioorg.2015.01.001
28. Blaskovich, M. A. T., Zuegg, J., Elliott, A. G., and Cooper, M. A. (2015) Helping chemists discover new antibiotics ACS Infect. Dis. 1, 285-287 10.1021/acsinfecdis.5b00044